JPH0261707B2 - - Google Patents
Info
- Publication number
- JPH0261707B2 JPH0261707B2 JP57165174A JP16517482A JPH0261707B2 JP H0261707 B2 JPH0261707 B2 JP H0261707B2 JP 57165174 A JP57165174 A JP 57165174A JP 16517482 A JP16517482 A JP 16517482A JP H0261707 B2 JPH0261707 B2 JP H0261707B2
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- groups
- protein
- group
- dye
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 15
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 13
- 102000004169 proteins and genes Human genes 0.000 claims description 34
- 108090000623 proteins and genes Proteins 0.000 claims description 34
- 238000006243 chemical reaction Methods 0.000 claims description 29
- 238000004519 manufacturing process Methods 0.000 claims description 13
- 125000003277 amino group Chemical group 0.000 claims description 12
- 125000003118 aryl group Chemical group 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 125000002877 alkyl aryl group Chemical group 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 239000000427 antigen Substances 0.000 claims description 7
- 102000036639 antigens Human genes 0.000 claims description 7
- 108091007433 antigens Proteins 0.000 claims description 7
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 6
- 230000001588 bifunctional effect Effects 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- 125000004434 sulfur atom Chemical group 0.000 claims description 3
- 238000004925 denaturation Methods 0.000 claims description 2
- 230000036425 denaturation Effects 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims 2
- 101710177166 Phosphoprotein Proteins 0.000 abstract 1
- 238000010166 immunofluorescence Methods 0.000 abstract 1
- 239000000975 dye Substances 0.000 description 27
- SHXOKQKTZJXHHR-UHFFFAOYSA-N n,n-diethyl-5-iminobenzo[a]phenoxazin-9-amine;hydrochloride Chemical compound [Cl-].C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4OC3=CC(=[NH2+])C2=C1 SHXOKQKTZJXHHR-UHFFFAOYSA-N 0.000 description 17
- 239000000243 solution Substances 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 8
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 7
- 229950003937 tolonium Drugs 0.000 description 7
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 6
- 108060003951 Immunoglobulin Proteins 0.000 description 5
- 102000018358 immunoglobulin Human genes 0.000 description 5
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 229920005654 Sephadex Polymers 0.000 description 3
- 239000012507 Sephadex⢠Substances 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 125000000853 cresyl group Chemical group C1(=CC=C(C=C1)C)* 0.000 description 3
- 238000000295 emission spectrum Methods 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 3
- -1 rhodamine isothiocyanate Chemical class 0.000 description 3
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- 125000000732 arylene group Chemical group 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 125000005442 diisocyanate group Chemical group 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000008057 potassium phosphate buffer Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- BCHZICNRHXRCHY-UHFFFAOYSA-N 2h-oxazine Chemical compound N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- ZHAFUINZIZIXFC-UHFFFAOYSA-N [9-(dimethylamino)-10-methylbenzo[a]phenoxazin-5-ylidene]azanium;chloride Chemical compound [Cl-].O1C2=CC(=[NH2+])C3=CC=CC=C3C2=NC2=C1C=C(N(C)C)C(C)=C2 ZHAFUINZIZIXFC-UHFFFAOYSA-N 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000002211 flavins Chemical class 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 230000035931 haemagglutination Effects 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229940098197 human immunoglobulin g Drugs 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910052754 neon Inorganic materials 0.000 description 1
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 108020001775 protein parts Proteins 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000010979 ruby Substances 0.000 description 1
- 229910001750 ruby Inorganic materials 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/80—Fluorescent dyes, e.g. rhodamine
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Luminescent Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Steroid Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
æ¬çºæã¯å
ç«èå
è©Šè¬ããã³ãã®è£œæ³ã«ä¿ã
ãã
ãã
èšåºæ€æ»ã«ãããŠãå
ç«æ³ã«ãã€ãŠãã«ã¢ã³ã
è¬ç©ãŸãã¯ä»£è¬ç©ã®åŠãå°éååç©ãå®éããã
ãšã¯ããããŠéèŠã§ãããå ç«åå¿ã®å®éæ³ã®ã
ã¡ïŒã€ã®æ¹æ³ã¯ãæåãŸãæäœããã«ãªã¬ã»ã€ã³
ãŸãã¯ããŒããã³ã€ãœããªã·ã¢ããŒãã®åŠãè¢å
çºè²å£ã§ããŒã¯ãããã®ã§ããããã®æ¹æ³ã®å©çš
ã«äŒŽãäž»ãªåé¡ç¹ã¯ãçååŠæ€äœã®åºæã®è¢å ã§
ãããããã«ã€ããŠããã©ãã³ãããªãžã³è£é µçŽ
ããã³è¡æž èçœè³ªã®åŠãå€ãã®ç©è³ªã¯ãè©Šæãšã
ãŠé垞䜿çšãããçºè²å£ãæŸå°ããã¹ãã¯ãã«å
ã§åŒ·ãè¢å ãçºããã
è¬ç©ãŸãã¯ä»£è¬ç©ã®åŠãå°éååç©ãå®éããã
ãšã¯ããããŠéèŠã§ãããå ç«åå¿ã®å®éæ³ã®ã
ã¡ïŒã€ã®æ¹æ³ã¯ãæåãŸãæäœããã«ãªã¬ã»ã€ã³
ãŸãã¯ããŒããã³ã€ãœããªã·ã¢ããŒãã®åŠãè¢å
çºè²å£ã§ããŒã¯ãããã®ã§ããããã®æ¹æ³ã®å©çš
ã«äŒŽãäž»ãªåé¡ç¹ã¯ãçååŠæ€äœã®åºæã®è¢å ã§
ãããããã«ã€ããŠããã©ãã³ãããªãžã³è£é µçŽ
ããã³è¡æž èçœè³ªã®åŠãå€ãã®ç©è³ªã¯ãè©Šæãšã
ãŠé垞䜿çšãããçºè²å£ãæŸå°ããã¹ãã¯ãã«å
ã§åŒ·ãè¢å ãçºããã
èµ€âè¿èµ€å€åïŒ600ãªãã900nmïŒããããã€ãŠ
æ€äœã®åºæè¢å ïŒ300ãªãã450nmïŒãããªãé¢
ããåã§è¢å ãçºããè©Šæã䜿çšããããšã«ã
ãã倩ç¶ç©ã«ããããã¯ã°ã©ãŠã³ããæé€ããã
ãšãã§ãã該æ¹æ³ã®æ床ãæ¹åããããšãå¯èœãš
ãªãã
æ€äœã®åºæè¢å ïŒ300ãªãã450nmïŒãããªãé¢
ããåã§è¢å ãçºããè©Šæã䜿çšããããšã«ã
ãã倩ç¶ç©ã«ããããã¯ã°ã©ãŠã³ããæé€ããã
ãšãã§ãã該æ¹æ³ã®æ床ãæ¹åããããšãå¯èœãš
ãªãã
溶液äžã§éé¢ããå€ãã®ææã¯ãè¢å
ã®åŒ·åºŠã
ããªã匱ããã®ã§ã¯ãã€ãŠãããããã®ç¹æ§ãæ
ããŠããããšã¯ç¥ãããŠãããããããªãããã
ã®æ§é ãä»ã®ååãšã®å ±æçµåã«ãã€ãŠäœããã®
æ¹æ³ã§å€æ§ãããå Žåã«ãããããã®ç¹æ§ãç¶æ
ãããããšã¯èªæãªããšã§ã¯ãªãã
ããªã匱ããã®ã§ã¯ãã€ãŠãããããã®ç¹æ§ãæ
ããŠããããšã¯ç¥ãããŠãããããããªãããã
ã®æ§é ãä»ã®ååãšã®å ±æçµåã«ãã€ãŠäœããã®
æ¹æ³ã§å€æ§ãããå Žåã«ãããããã®ç¹æ§ãç¶æ
ãããããšã¯èªæãªããšã§ã¯ãªãã
æ¬çºæè
ãã¯ãè¿èµ€å€åã§è¢å
ãçºããææ
ããè¢å çºè²å£ã®âNH2åºãšåå¿ããäºå®èœæ§
ç©è³ªã䜿çšããŠãåçš®ã®èçœè³ªã«å ±æçµåããã
å Žåã«ãããããææã¯ãã®ã¹ãã¯ãã«ç¹æ§ã倱
ãªããªããšã®çµæãåŸãŠãæ¬çºæã«è³ã€ãããã®
å Žåãè¢å ã¯ïŒãªããïŒåã«å¢å€§ããïŒç¬¬ïŒå³ã
ãã³ç¬¬ïŒå³åç §ïŒã
ããè¢å çºè²å£ã®âNH2åºãšåå¿ããäºå®èœæ§
ç©è³ªã䜿çšããŠãåçš®ã®èçœè³ªã«å ±æçµåããã
å Žåã«ãããããææã¯ãã®ã¹ãã¯ãã«ç¹æ§ã倱
ãªããªããšã®çµæãåŸãŠãæ¬çºæã«è³ã€ãããã®
å Žåãè¢å ã¯ïŒãªããïŒåã«å¢å€§ããïŒç¬¬ïŒå³ã
ãã³ç¬¬ïŒå³åç §ïŒã
第ïŒå³ã¯æγâå
ç«ã°ãããªã³âãã€ã«ãã«ãŒ
è€åäœïŒæ²ç·ïŒïŒããã³ãã€ã«ãã«ãŒæº¶æ¶²ïŒæ²ç·
ïŒïŒã®çºå ã¹ãã¯ãã«ã瀺ããçºè²å£ã®æ¿åºŠã¯ïŒ
Ã10-6Mã§ãããå±èµ·æ³¢é·ã¯600nmã§ãããã¹ã
ã¯ãã«ã¯ãå é»åå¢å管HAMAMATSU R446
ãå ·åããåå è¢å å 床èšPerkinâElmer MPE
â2Aã«ãã枬å®ãããã®ã§ãããå³äžã暪軞ã¯
æ³¢é·ïŒnmïŒã瀺ãã瞊軞ã¯è¢å ã瀺ãã
è€åäœïŒæ²ç·ïŒïŒããã³ãã€ã«ãã«ãŒæº¶æ¶²ïŒæ²ç·
ïŒïŒã®çºå ã¹ãã¯ãã«ã瀺ããçºè²å£ã®æ¿åºŠã¯ïŒ
Ã10-6Mã§ãããå±èµ·æ³¢é·ã¯600nmã§ãããã¹ã
ã¯ãã«ã¯ãå é»åå¢å管HAMAMATSU R446
ãå ·åããåå è¢å å 床èšPerkinâElmer MPE
â2Aã«ãã枬å®ãããã®ã§ãããå³äžã暪軞ã¯
æ³¢é·ïŒnmïŒã瀺ãã瞊軞ã¯è¢å ã瀺ãã
第ïŒå³ã¯ã¢ã«ãŽã³ã¬ãŒã¶ãŒã«ããλïŒ515nmã§
å±èµ·ããããšã«ããåŸããããProtein âãã€
ã«ãã«ãŒè€åäœïŒæ²ç·ïŒïŒãHCSâãã€ã«ãã«ãŒ
è€åäœïŒæ²ç·ïŒïŒããã³ãã€ã«ãã«ãŒåç¬ïŒæ²ç·
ïŒïŒã®çºå ã¹ãã¯ãã«ã瀺ããçºè²å£ã®æ¿åºŠã¯ïŒ
Ã10-6Mã§ããã暪軞ã¯æ³¢é·ïŒnmïŒã瀺ãã瞊
軞ã¯è¢å ã瀺ãã
å±èµ·ããããšã«ããåŸããããProtein âãã€
ã«ãã«ãŒè€åäœïŒæ²ç·ïŒïŒãHCSâãã€ã«ãã«ãŒ
è€åäœïŒæ²ç·ïŒïŒããã³ãã€ã«ãã«ãŒåç¬ïŒæ²ç·
ïŒïŒã®çºå ã¹ãã¯ãã«ã瀺ããçºè²å£ã®æ¿åºŠã¯ïŒ
Ã10-6Mã§ããã暪軞ã¯æ³¢é·ïŒnmïŒã瀺ãã瞊
軞ã¯è¢å ã瀺ãã
äžè¬ã«ãæ¶æ©å€ã«ããè¡šãããäºå®èœæ§ç©è³ª
ã¯ãèçœè³ªããã³ææã®äž¡è ãšçŽæ¥åå¿ããäžèš
ã®äžè¬åŒã§è¡šããããé¯äœã圢æãã ãææãâoLnã»èçœè³ª äºå®èœæ§ç©è³ªãã«ã«ããžã€ããã§ããå Žåã«
ã¯ããããåå¿äœã¯äœçšããã«ã«ããã·ã«åºã掻
æ§åããŠã«ã«ããã·ã«åºãšææã®ã¢ããåºãšã®é
ã§ã«ã«ãã¢ããçµåã圢æããããã次åŒã§è¡šã
ãããé¯äœãçæãããã
ã¯ãèçœè³ªããã³ææã®äž¡è ãšçŽæ¥åå¿ããäžèš
ã®äžè¬åŒã§è¡šããããé¯äœã圢æãã ãææãâoLnã»èçœè³ª äºå®èœæ§ç©è³ªãã«ã«ããžã€ããã§ããå Žåã«
ã¯ããããåå¿äœã¯äœçšããã«ã«ããã·ã«åºã掻
æ§åããŠã«ã«ããã·ã«åºãšææã®ã¢ããåºãšã®é
ã§ã«ã«ãã¢ããçµåã圢æããããã次åŒã§è¡šã
ãããé¯äœãçæãããã
ãããè€åäœã®èçœè³ªéšåããã®çååŠç¹æ§ã
ããšãã°æåãŸãã¯æäœã§ããå Žåã«ã¯å ç«æ§ã
ãç¶æããŠããã
ããšãã°æåãŸãã¯æäœã§ããå Žåã«ã¯å ç«æ§ã
ãç¶æããŠããã
ãããå
ç«èå
è©Šè¬ã䜿çšããå Žåã«ããè£
眮
ã«ãããç¹å¥ãªå€æŽã¯ãªããããªãã¡ãéåžžã®å
å è¢å å 床èšã«èµ€å€ç·æå¿å é»åå¢å管ãåä»ã
ãã ãã§ãããç¹æ®ãªæ床ã®æž¬å®ã¯ãããªãŠã â
ããªã³ã¬ãŒã¶ãŒãã«ããŒã¬ãŒã¶ãŒãŸãã¯ç°¡äŸ¿ã«ã¯
è²çŽ ã¬ãŒã¶ãŒã®åŠãèµ€è²å ãŸãã¯è¿èµ€å€ã®é£ç¶ã¬
ãŒã¶ãŒãŸãã¯ãã«ã¹åã¬ãŒã¶ãŒã«ããè¢å çºè²å£
ãå±èµ·ãããããšã«ããè¡ãªãããã
ã«ãããç¹å¥ãªå€æŽã¯ãªããããªãã¡ãéåžžã®å
å è¢å å 床èšã«èµ€å€ç·æå¿å é»åå¢å管ãåä»ã
ãã ãã§ãããç¹æ®ãªæ床ã®æž¬å®ã¯ãããªãŠã â
ããªã³ã¬ãŒã¶ãŒãã«ããŒã¬ãŒã¶ãŒãŸãã¯ç°¡äŸ¿ã«ã¯
è²çŽ ã¬ãŒã¶ãŒã®åŠãèµ€è²å ãŸãã¯è¿èµ€å€ã®é£ç¶ã¬
ãŒã¶ãŒãŸãã¯ãã«ã¹åã¬ãŒã¶ãŒã«ããè¢å çºè²å£
ãå±èµ·ãããããšã«ããè¡ãªãããã
ãããã®è€åäœãç¹ã«è¢å
æäœãæ€é¡ã®é䜿çš
ããããšã¯ãäœãåé¡ç¹ãçãããã®ã§ã¯ãªãã
èµ€å€ç·æå ãã€ã«ã ãå¿ èŠãšãããã®ã¿ã§ããã
ãŸããåäžæ€é¡ãã¬ããŒã©ãã«ãããŠãã¹ãã¯ã
ã«ã®ç·âé»è²åã§è¢å ãçºããåŸæ¥ã®è¢å çºè²å£
ã«ããããŒã¯ããæäœã§çè²ããåºåã«å¯ŸããŠã®
èå¥ãå¯èœã«ãªãå©ç¹ãããã
ããããšã¯ãäœãåé¡ç¹ãçãããã®ã§ã¯ãªãã
èµ€å€ç·æå ãã€ã«ã ãå¿ èŠãšãããã®ã¿ã§ããã
ãŸããåäžæ€é¡ãã¬ããŒã©ãã«ãããŠãã¹ãã¯ã
ã«ã®ç·âé»è²åã§è¢å ãçºããåŸæ¥ã®è¢å çºè²å£
ã«ããããŒã¯ããæäœã§çè²ããåºåã«å¯ŸããŠã®
èå¥ãå¯èœã«ãªãå©ç¹ãããã
æ¬çºæã¯ãäžèšäžè¬åŒãæããæ°èŠãªå
ç«èå
è©Šè¬ã«ä¿ããã
è©Šè¬ã«ä¿ããã
åŒäžã
ïœïŒïŒãªããïŒã®æŽæ°
ïœïŒïœã«çããæŽæ°ïŒãã ããæ¶æ©å€ãã«ã«ãã€
ããã®å Žåã«ã¯ãïœïŒïŒïŒ ïŒæåãŸãã¯æäœããéžã°ããèçœè³ª ïŒæ¶æ©å€æ®åº ïŒé žçŽ ãŸãã¯ã€ãªãŠåå ïŒNHãNH2ãNRâ³ãNRâ²Râ³ïŒãã§Râ²ããã³
Râ³ã¯åäžãŸãã¯ç°ãªã眮æãŸãã¯æªçœ®æã®
ã¢ã«ãã«åºãã¢ãªãŒã«åºãã¢ãªãŒã«ã¢ã«ãã«
åºãŸãã¯ã¢ã«ãã«ã¢ãªãŒã«åºã§ããïŒãŸãã¯
OCORâ²ïŒããã§Râ²ã¯åèšãšåæ矩ã§ããïŒã®
äžããéžã°ããåº R1ãR2ãR3ãR4ãR5ãR7ããã³R8ïŒåäžãŸãã¯
ç°ãªãæ°ŽçŽ ååãŸãã¯ã¢ããåºããŸãã¯çœ®æ
ãŸãã¯æªçœ®æã®ã¢ã«ãã«åºãã¢ãªãŒã«åºãã¢
ã«ãã«ã¢ãªãŒã«åºãŸãã¯ã¢ãªãŒã«ã¢ã«ãã«åº
ïŒR1ããã³R2ããã³ïŒãŸãã¯R7ããã³R8ã¯
äºãã«çµåããŠè³éŠç°ãšã®çž®åç°ã圢æãã
ïŒäŸ¡ã®åºã§ãã€ãŠãããããããã®ãã¡å°ãª
ããšãïŒã€ïŒå€ãã®å ŽåR3ïŒã¯æ¶æ©å€ãšã®
åå¿ã®éãâNHâãŸãã¯âïŒïŒ¬âåºã
圢æããã¢ããåºã§ãªããã°ãªããªããïŒ äžèšè©Šè¬ã¯ã以äžã®å矀ããéžã°ããåã å°ãª
ããšãïŒçš®é¡ã®ååç©ãåå¿ãããããšã«ãã調
補ãããã
ããã®å Žåã«ã¯ãïœïŒïŒïŒ ïŒæåãŸãã¯æäœããéžã°ããèçœè³ª ïŒæ¶æ©å€æ®åº ïŒé žçŽ ãŸãã¯ã€ãªãŠåå ïŒNHãNH2ãNRâ³ãNRâ²Râ³ïŒãã§Râ²ããã³
Râ³ã¯åäžãŸãã¯ç°ãªã眮æãŸãã¯æªçœ®æã®
ã¢ã«ãã«åºãã¢ãªãŒã«åºãã¢ãªãŒã«ã¢ã«ãã«
åºãŸãã¯ã¢ã«ãã«ã¢ãªãŒã«åºã§ããïŒãŸãã¯
OCORâ²ïŒããã§Râ²ã¯åèšãšåæ矩ã§ããïŒã®
äžããéžã°ããåº R1ãR2ãR3ãR4ãR5ãR7ããã³R8ïŒåäžãŸãã¯
ç°ãªãæ°ŽçŽ ååãŸãã¯ã¢ããåºããŸãã¯çœ®æ
ãŸãã¯æªçœ®æã®ã¢ã«ãã«åºãã¢ãªãŒã«åºãã¢
ã«ãã«ã¢ãªãŒã«åºãŸãã¯ã¢ãªãŒã«ã¢ã«ãã«åº
ïŒR1ããã³R2ããã³ïŒãŸãã¯R7ããã³R8ã¯
äºãã«çµåããŠè³éŠç°ãšã®çž®åç°ã圢æãã
ïŒäŸ¡ã®åºã§ãã€ãŠãããããããã®ãã¡å°ãª
ããšãïŒã€ïŒå€ãã®å ŽåR3ïŒã¯æ¶æ©å€ãšã®
åå¿ã®éãâNHâãŸãã¯âïŒïŒ¬âåºã
圢æããã¢ããåºã§ãªããã°ãªããªããïŒ äžèšè©Šè¬ã¯ã以äžã®å矀ããéžã°ããåã å°ãª
ããšãïŒçš®é¡ã®ååç©ãåå¿ãããããšã«ãã調
補ãããã
(a) æåãŸãã¯æäœããéžã°ããèçœè³ª
(b) äžè¬åŒ
ïŒåŒäžãR1ãR2ãR3ãR4ãR5ãR7ãR8ãã
ãã³ïŒ¹ã¯åèšãšåæ矩ã§ããïŒã§è¡šãããå¯èŠ
åã«åžåïŒÎ»maxã¯550ãªãã800nmïŒãæã
ãã€å°ãªããšãïŒã€ã®éé¢NH2ããã³600ãªã
ã900nmã§ã®è¢å ãæãããªããµãžã³ãŸãã¯ã
ã¢ãžã³ããéžã°ãææ (c) æ¶æ©å€ïŒäžè¬ã«ãææã®ã¢ããåºãšåå¿ãã
ãåºãæããäºå®èœæ§ç©è³ªïŒ å矀ãæ§æããããã€ãã®ååç©ãåèã®ãã
ã«äŸç€ºããã
ãã³ïŒ¹ã¯åèšãšåæ矩ã§ããïŒã§è¡šãããå¯èŠ
åã«åžåïŒÎ»maxã¯550ãªãã800nmïŒãæã
ãã€å°ãªããšãïŒã€ã®éé¢NH2ããã³600ãªã
ã900nmã§ã®è¢å ãæãããªããµãžã³ãŸãã¯ã
ã¢ãžã³ããéžã°ãææ (c) æ¶æ©å€ïŒäžè¬ã«ãææã®ã¢ããåºãšåå¿ãã
ãåºãæããäºå®èœæ§ç©è³ªïŒ å矀ãæ§æããããã€ãã®ååç©ãåèã®ãã
ã«äŸç€ºããã
èçœè³ª
(i) ã¹ã¿ãã€ãã³ãã«ã¹ ã¢ãŠã¬ãŠã¹
ïŒStaphylococcous aureusïŒããã®Protein  (ii) ãã«ã¢ã³èçœè³ª (iii) åçš®ã®Î³âå ç«ã°ãããªã³ïŒIgïŒïŒããšãã°
IgGãIgMãIgAãIgDãIgEïŒ æ æ (i) ãã€ã«ãã«ãŒïŒC.I.51180ïŒ (ii) ã¯ã¬ãžã«ãã€ãªã¬ããïŒCresyl violetïŒ (iii) ãã«ã€ãžã³ãã«ãŒïŒC.I.52040ïŒ (iv) ããªãªã¢ã³ãã¯ã¬ãžã«ãã«ãŒïŒC.I.51010ïŒ æ¶æ©å€ (i) äžè¬åŒ ïŒïŒ£ïŒïŒ®ââïŒïŒ£ïŒïŒ¯ ïŒããã§ïŒ²ã¯çœ®æãŸãã¯æªçœ®æã®ã¢ã«ãã¬ã³
åºãã¢ãªãŒã¬ã³åºãã¢ã«ãã«ã¢ãªãŒã¬ã³åºãŸã
ã¯ã¢ãªãŒã«ã¢ã«ãã¬ã³åºã§ããïŒã§è¡šãããã
ãžã€ãœã·ã¢ããŒã (ii) äžè¬åŒ âïŒïŒ£ïŒïŒ®âRâ² ïŒããã§ïŒ²ããã³Râ²ã¯åäžãŸãã¯ç°ãªã眮æ
ãŸãã¯æªçœ®æã®ã¢ã«ãã«åºãã¢ãªãŒã«åºãã¢ã«
ãã«ã¢ãªãŒã«åºãŸãã¯ã¢ãªãŒã«ã¢ã«ãã«åºã§ã
ãïŒã§è¡šããããã«ã«ããžã€ãã (iii) äžè¬åŒ CHOââCHO ïŒããã§ïŒ²ã¯çœ®æãŸãã¯æªçœ®æã®ã¢ã«ãã¬ã³
åºãã¢ãªãŒã¬ã³åºãã¢ã«ãã«ã¢ãªãŒã¬ã³åºãŸã
ã¯ã¢ãªãŒã«ã¢ã«ãã¬ã³åºã§ããïŒã§è¡šãããã
ãžã¢ã«ããã (iv) æ§é åŒ ã§è¡šãããããšãã¬ã³âç¡æ°Žãã¬ã€ã³é žå ±éå
äœïŒEMAïŒ (v) åŒ ãæãããžããããã³ãŒã³ ãããïŒã€ã®ååç©ã®éã®åå¿ã¯ããããåå
ç©ãåç¬ã§äœ¿çšããŠè¡ãªãããšãã§ãããŸããã
ãååç©çšã®æº¶åªãããšãã°æ°Žãå°ãªããšãïŒçš®
é¡ã®å¡©ã®æ°Žæº¶æ¶²ãŸãã¯ç·©è¡å€æ··åç©ã®ååšäžã§ã
è¡ãªãããšãã§ããã溶åªã®PHã¯4.5ãªãã9.5
ã§ãææã®æº¶è§£åºŠãé«ããããã«å°éã®ææ©æº¶åª
ãæ·»å ããŠããããåå¿æž©åºŠã¯ã»ãŒå®€æž©ïŒïŒãïŒ
âãªããèçœè³ªå€æ§æž©åºŠïŒã§ããã
ïŒStaphylococcous aureusïŒããã®Protein  (ii) ãã«ã¢ã³èçœè³ª (iii) åçš®ã®Î³âå ç«ã°ãããªã³ïŒIgïŒïŒããšãã°
IgGãIgMãIgAãIgDãIgEïŒ æ æ (i) ãã€ã«ãã«ãŒïŒC.I.51180ïŒ (ii) ã¯ã¬ãžã«ãã€ãªã¬ããïŒCresyl violetïŒ (iii) ãã«ã€ãžã³ãã«ãŒïŒC.I.52040ïŒ (iv) ããªãªã¢ã³ãã¯ã¬ãžã«ãã«ãŒïŒC.I.51010ïŒ æ¶æ©å€ (i) äžè¬åŒ ïŒïŒ£ïŒïŒ®ââïŒïŒ£ïŒïŒ¯ ïŒããã§ïŒ²ã¯çœ®æãŸãã¯æªçœ®æã®ã¢ã«ãã¬ã³
åºãã¢ãªãŒã¬ã³åºãã¢ã«ãã«ã¢ãªãŒã¬ã³åºãŸã
ã¯ã¢ãªãŒã«ã¢ã«ãã¬ã³åºã§ããïŒã§è¡šãããã
ãžã€ãœã·ã¢ããŒã (ii) äžè¬åŒ âïŒïŒ£ïŒïŒ®âRâ² ïŒããã§ïŒ²ããã³Râ²ã¯åäžãŸãã¯ç°ãªã眮æ
ãŸãã¯æªçœ®æã®ã¢ã«ãã«åºãã¢ãªãŒã«åºãã¢ã«
ãã«ã¢ãªãŒã«åºãŸãã¯ã¢ãªãŒã«ã¢ã«ãã«åºã§ã
ãïŒã§è¡šããããã«ã«ããžã€ãã (iii) äžè¬åŒ CHOââCHO ïŒããã§ïŒ²ã¯çœ®æãŸãã¯æªçœ®æã®ã¢ã«ãã¬ã³
åºãã¢ãªãŒã¬ã³åºãã¢ã«ãã«ã¢ãªãŒã¬ã³åºãŸã
ã¯ã¢ãªãŒã«ã¢ã«ãã¬ã³åºã§ããïŒã§è¡šãããã
ãžã¢ã«ããã (iv) æ§é åŒ ã§è¡šãããããšãã¬ã³âç¡æ°Žãã¬ã€ã³é žå ±éå
äœïŒEMAïŒ (v) åŒ ãæãããžããããã³ãŒã³ ãããïŒã€ã®ååç©ã®éã®åå¿ã¯ããããåå
ç©ãåç¬ã§äœ¿çšããŠè¡ãªãããšãã§ãããŸããã
ãååç©çšã®æº¶åªãããšãã°æ°Žãå°ãªããšãïŒçš®
é¡ã®å¡©ã®æ°Žæº¶æ¶²ãŸãã¯ç·©è¡å€æ··åç©ã®ååšäžã§ã
è¡ãªãããšãã§ããã溶åªã®PHã¯4.5ãªãã9.5
ã§ãææã®æº¶è§£åºŠãé«ããããã«å°éã®ææ©æº¶åª
ãæ·»å ããŠããããåå¿æž©åºŠã¯ã»ãŒå®€æž©ïŒïŒãïŒ
âãªããèçœè³ªå€æ§æž©åºŠïŒã§ããã
èçœè³ªâèçœè³ªéã®åå¿ãé²æ¢ãããããèçœ
質ã«å¯ŸããŠå€§éå°éïŒïŒãªãã50åã®ã¢ã«æ¿åºŠïŒ
ã®ææã䜿çšããŠåå¿ãè¡ãªãã
質ã«å¯ŸããŠå€§éå°éïŒïŒãªãã50åã®ã¢ã«æ¿åºŠïŒ
ã®ææã䜿çšããŠåå¿ãè¡ãªãã
ãŸããèçœè³ªãšææãšã®ç·éã«å¯ŸããŠå€§éå°é
ã®æ¶æ©å€ã䜿çšããŠåå¿ãè¡ãªãã
ã®æ¶æ©å€ã䜿çšããŠåå¿ãè¡ãªãã
æäœäžã®è©³çŽ°ã«ã€ããŠã¯ä»¥äžã®å®æœäŸã«ããæ
ããã«ãªãã§ããããããããªããããããã®å®
æœäŸã¯æ¬çºæãéå®ãããã®ã§ã¯ãªãããããªã
çš®é¡ã®ç©è³ªã«ã€ããŠãæå©ã«é©çšã§ããã
ããã«ãªãã§ããããããããªããããããã®å®
æœäŸã¯æ¬çºæãéå®ãããã®ã§ã¯ãªãããããªã
çš®é¡ã®ç©è³ªã«ã€ããŠãæå©ã«é©çšã§ããã
å®æœäŸ ïŒ
æããå
ç«ã°ãããªã³ïŒ§å®¶å
è¡æž
ïŒæãã
IgGïŒã®å ç«ã°ãããªã³ãã©ã¯ã·ãšã³ããäºå®èœ
æ§ç©è³ªãšããŠã°ã«ã¿ã«ã¢ã«ãããã䜿çšããŠãã
ã€ã«ãã«ãŒïŒïŒ£ã»I.51180ïŒããã³ãã«ã€ãžã³ã
ã«ãŒïŒC.I.52040ïŒã§ããŒã¯ããã
IgGïŒã®å ç«ã°ãããªã³ãã©ã¯ã·ãšã³ããäºå®èœ
æ§ç©è³ªãšããŠã°ã«ã¿ã«ã¢ã«ãããã䜿çšããŠãã
ã€ã«ãã«ãŒïŒïŒ£ã»I.51180ïŒããã³ãã«ã€ãžã³ã
ã«ãŒïŒC.I.52040ïŒã§ããŒã¯ããã
ãŸãããªã³é
žã«ãªãŠã ç·©è¡å€ïŒ0.01MïŒPH7.1ïŒ
ïŒmläžã«æããIgG2mgããã³ãã€ã«ãã«ãŒ1.3Ã
10-4ããªã¢ã«ãå«æãã溶液ã«ãæçµã®ã°ã«ã¿ã«
ã¢ã«ãããæ¿åºŠã0.05ïŒ ãšãªããŸã§ã°ã«ã¿ã«ã¢ã«
ããããæ·»å ããã宀枩ã«ãããŠæ¹æããªããå
å¿ã30åéè¡ãªããã€ãã§éé¢ã®ã¢ã«ãããåºã
äºç¡«é žæ°ŽçŽ ãããªãŠã ã«ããæéããããšã«ãã
åå¿ãåæ¢ãããSephadex G25ã®ã¯ãããã°ã©
ãã€ãŒã«ããæªåå¿ã®ææãé€å»ããã
ïŒmläžã«æããIgG2mgããã³ãã€ã«ãã«ãŒ1.3Ã
10-4ããªã¢ã«ãå«æãã溶液ã«ãæçµã®ã°ã«ã¿ã«
ã¢ã«ãããæ¿åºŠã0.05ïŒ ãšãªããŸã§ã°ã«ã¿ã«ã¢ã«
ããããæ·»å ããã宀枩ã«ãããŠæ¹æããªããå
å¿ã30åéè¡ãªããã€ãã§éé¢ã®ã¢ã«ãããåºã
äºç¡«é žæ°ŽçŽ ãããªãŠã ã«ããæéããããšã«ãã
åå¿ãåæ¢ãããSephadex G25ã®ã¯ãããã°ã©
ãã€ãŒã«ããæªåå¿ã®ææãé€å»ããã
代衚çãªå®éšäŸã§ã¯ãèçœè³ªïŒææã®ã¢ã«æ¯ã
ïŒïŒ1.8ã®è¢å æããIgGâãã€ã«ãã«ãŒè€åäœã
ãããã¯ïŒïŒ1.2ã®æããIgGâãã«ã€ãžã³ãã«ãŒ
è€åäœãåŸãããã
ïŒïŒ1.8ã®è¢å æããIgGâãã€ã«ãã«ãŒè€åäœã
ãããã¯ïŒïŒ1.2ã®æããIgGâãã«ã€ãžã³ãã«ãŒ
è€åäœãåŸãããã
ææã®æ¿åºŠãããã€ã«ãã«ãŒã«ã€ããŠã¯ã¢ã«åž
åä¿æ°5.8Ã104ã䜿çšããŠÎ»ïŒ635nmã«ãããŠã
ãã«ã€ãžã³ãã«ãŒã«ã€ããŠã¯ã¢ã«åžåä¿æ°3.1Ã
104ã䜿çšããŠÎ»ïŒ620nmã«ãããŠæž¬å®ããã
åä¿æ°5.8Ã104ã䜿çšããŠÎ»ïŒ635nmã«ãããŠã
ãã«ã€ãžã³ãã«ãŒã«ã€ããŠã¯ã¢ã«åžåä¿æ°3.1Ã
104ã䜿çšããŠÎ»ïŒ620nmã«ãããŠæž¬å®ããã
èçœè³ªæ¿åºŠã«ã€ããŠã¯ãεïŒïŒ
ïŒïŒ14ãλïŒ
280nmã䜿çšãã玫å€åã§ã®ææã®åžåãè£æ£ã
ãããšã«ããããããã¯ã±ã«ããŒã«ãã¯ãæ³ã«ã
ãçªçŽ ã枬å®ããããšã«ããç®å®ããã
280nmã䜿çšãã玫å€åã§ã®ææã®åžåãè£æ£ã
ãããšã«ããããããã¯ã±ã«ããŒã«ãã¯ãæ³ã«ã
ãçªçŽ ã枬å®ããããšã«ããç®å®ããã
äž¡è€åäœãšããçµåããå
ç«ã°ãããªã³ã®æäœ
ç¹æ§ãæ確ã«ç¶æããŠããã
ç¹æ§ãæ確ã«ç¶æããŠããã
å®æœäŸ ïŒ
äºå®èœæ§ç©è³ªãšããŠã°ã«ã¿ã«ã¢ã«ãããã䜿çš
ãããã絚æ¯èæ§ãœãããã¢ãããã³ïŒHCSïŒ
ãšãªããµãžã³ç³»ææãããªãã¡ããªãªã¢ã³ãã¯ã¬
ãžã«ãã«ãŒïŒC.I.51010ïŒãšã®éã®è€åäœã調補
ããã
ãããã絚æ¯èæ§ãœãããã¢ãããã³ïŒHCSïŒ
ãšãªããµãžã³ç³»ææãããªãã¡ããªãªã¢ã³ãã¯ã¬
ãžã«ãã«ãŒïŒC.I.51010ïŒãšã®éã®è€åäœã調補
ããã
HCS2.5mgããã³ææïŒÃ10-4ããªã¢ã«ãå«æ
ãããªã³é žãããªãŠã ç·©è¡å€ïŒ0.05MãPH7.8ïŒ
ïŒmlã«ãæçµã°ã«ã¿ã«ã¢ã«ãããæ¿åºŠã0.1ïŒ ãš
ãªããŸã§ãã°ã«ã¿ã«ã¢ã«ããããæ·»å ããã宀枩
ã§ïŒæéåå¿ãè¡ãªã€ãã®ã¡ãå®æœäŸ11ã®åãå
å¿æº¶æ¶²ãåŠçããŠHCSïŒããªãªã¢ã³ãã¯ã¬ãžã«
ãã«ãŒã®ã¢ã«æ¯ãïŒïŒïŒã®è€åäœãåŸãã
ãããªã³é žãããªãŠã ç·©è¡å€ïŒ0.05MãPH7.8ïŒ
ïŒmlã«ãæçµã°ã«ã¿ã«ã¢ã«ãããæ¿åºŠã0.1ïŒ ãš
ãªããŸã§ãã°ã«ã¿ã«ã¢ã«ããããæ·»å ããã宀枩
ã§ïŒæéåå¿ãè¡ãªã€ãã®ã¡ãå®æœäŸ11ã®åãå
å¿æº¶æ¶²ãåŠçããŠHCSïŒããªãªã¢ã³ãã¯ã¬ãžã«
ãã«ãŒã®ã¢ã«æ¯ãïŒïŒïŒã®è€åäœãåŸãã
ææã®å²åã«ã€ããŠã¯ã¢ã«åžåä¿æ°16500ã䜿
çšããŠÎ»ïŒ633ã«ãããŠãHCSã«ã€ããŠã¯ÎµïŒïŒ ïŒ
ïŒ8.3ã䜿çšããŠÎ»ïŒ278ã«ãããŠæž¬å®ããã
çšããŠÎ»ïŒ633ã«ãããŠãHCSã«ã€ããŠã¯ÎµïŒïŒ ïŒ
ïŒ8.3ã䜿çšããŠÎ»ïŒ278ã«ãããŠæž¬å®ããã
å®æœäŸ ïŒ
æ¶æ©å€ãšããŠã°ã«ã¿ã«ã¢ã«ãããã䜿çšããå®
æœäŸïŒãšåãæ¡ä»¶äžã§ããã€ã«ãã«ãŒãšã¹ã¿ãã€
ãã³ãã«ã¹ ã¢ãŠã¬ãŠã¹ããã®Protein ãšã®é
ã®è€åäœã調補ããã
æœäŸïŒãšåãæ¡ä»¶äžã§ããã€ã«ãã«ãŒãšã¹ã¿ãã€
ãã³ãã«ã¹ ã¢ãŠã¬ãŠã¹ããã®Protein ãšã®é
ã®è€åäœã調補ããã
ãã®è€åäœã®èçœè³ªïŒææã®ã¢ã«æ¯ã¯ïŒïŒ1.5
ã§ãã€ãã
ã§ãã€ãã
ãã®å ŽåãProtein ã®æž¬å®ã«ããããã±ã«ã
ãŒã«ãã¯ãæ³ã䜿çšããªãå Žåã«ã¯ãεïŒïŒ ïŒïŒ
1.65ãλïŒ275ã䜿çšããã
ãŒã«ãã¯ãæ³ã䜿çšããªãå Žåã«ã¯ãεïŒïŒ ïŒïŒ
1.65ãλïŒ275ã䜿çšããã
å®æœäŸ ïŒ
æ§é åŒ
ãæãããã«ã€ã¬ã³âïŒïŒïŒâãžã€ãœã·ã¢ããŒã
ïŒTDICïŒãäºå®èœæ§ç©è³ªãšããŠäœ¿çšããæãã
å ç«ã°ãããªã³ïŒæããIgGïŒããã€ã«ãã«ãŒ
ïŒC.I.51180ïŒã§ããŒã¯ããã
ïŒTDICïŒãäºå®èœæ§ç©è³ªãšããŠäœ¿çšããæãã
å ç«ã°ãããªã³ïŒæããIgGïŒããã€ã«ãã«ãŒ
ïŒC.I.51180ïŒã§ããŒã¯ããã
åå¿ãïŒæ®µéã§è¡ãªã€ãã第ïŒæ®µéã§ã¯ãïŒäœ
ã®ã€ãœã·ã¢ããŒãåºãæããIgGã®NH2ãšåå¿ã
ããã第ïŒæ®µéã§ã¯ãéé¢ã®TDICãå«æããªã
æããIgGâTDICè€åäœã«37âã§ãã€ã«ãã«ãŒ
ãæ·»å ãã第ïŒã®ã€ãœã·ã¢ããŒãåºãææã®ã¢ã
ãåºãšåå¿ãããã
ã®ã€ãœã·ã¢ããŒãåºãæããIgGã®NH2ãšåå¿ã
ããã第ïŒæ®µéã§ã¯ãéé¢ã®TDICãå«æããªã
æããIgGâTDICè€åäœã«37âã§ãã€ã«ãã«ãŒ
ãæ·»å ãã第ïŒã®ã€ãœã·ã¢ããŒãåºãææã®ã¢ã
ãåºãšåå¿ãããã
å·¥çšïŒ
ãªã³é
žã«ãªãŠã ç·©è¡å€ïŒPH4.5ã0.05MïŒäžã«
γâå ç«ã°ãããªã³ïŒmgãå«ã溶液ïŒïŒâã«å·åŽ
ãããã®ïŒã«TDIC0.05mlãæ·»å ãããæ¿ããæ¹
æããªããïŒâã§çŽ30åéåå¿ãè¡ãªããæ··åç©
ãé å¿åé¢ããŠïŒâã«ãããŠæ°Žæº¶æ¶²äžã§æ²æ®¿ãã
æªåå¿ã®ãžã€ãœã·ã¢ããŒããé€å»ããã溶解ãã
TDICãåå¿ããããããäžæž 液ãïŒâã§ããã«
ïŒæéåå¿ãããã
γâå ç«ã°ãããªã³ïŒmgãå«ã溶液ïŒïŒâã«å·åŽ
ãããã®ïŒã«TDIC0.05mlãæ·»å ãããæ¿ããæ¹
æããªããïŒâã§çŽ30åéåå¿ãè¡ãªããæ··åç©
ãé å¿åé¢ããŠïŒâã«ãããŠæ°Žæº¶æ¶²äžã§æ²æ®¿ãã
æªåå¿ã®ãžã€ãœã·ã¢ããŒããé€å»ããã溶解ãã
TDICãåå¿ããããããäžæž 液ãïŒâã§ããã«
ïŒæéåå¿ãããã
å·¥çšïŒ
å·¥çšïŒã®æº¶æ¶²ã«ããã€ã«ãã«ãŒ10-4ããªã¢ã«ã
å«æãããªã³é žå¡©ç·©è¡å€0.1mlãæ·»å ãããåå¿
溶液ã37âã§ïŒæéæ¹æããã€ãã§æªåå¿ã€ãœã·
ã¢ããŒãåºãå解ããããã«0.1Mçé žã¢ã³ã¢ã
ãŠã ã«å¯ŸããŠéæãããéé¢ã®ææã«ã€ããŠã¯ã
èžçæ°ŽãŸãã¯äžæ§ã®ç·©è¡å€ã«å¯Ÿããéæããã³
Sephadex G25ã®ã¯ãããã°ã©ãã€ãŒã«ããé€å»
ããã
å«æãããªã³é žå¡©ç·©è¡å€0.1mlãæ·»å ãããåå¿
溶液ã37âã§ïŒæéæ¹æããã€ãã§æªåå¿ã€ãœã·
ã¢ããŒãåºãå解ããããã«0.1Mçé žã¢ã³ã¢ã
ãŠã ã«å¯ŸããŠéæãããéé¢ã®ææã«ã€ããŠã¯ã
èžçæ°ŽãŸãã¯äžæ§ã®ç·©è¡å€ã«å¯Ÿããéæããã³
Sephadex G25ã®ã¯ãããã°ã©ãã€ãŒã«ããé€å»
ããã
åŸãããè€åäœã«ãããèçœè³ªïŒãã€ã«ãã«ãŒ
ã®ã¢ã«æ¯ã¯ïŒïŒ2.4ã§ãã€ãããªãããããã®ç®
å®ã«ããã€ãŠã¯ãå®æœäŸïŒã§èçœè³ªããã³ææã«
ã€ããŠç€ºããæ¹æ³ããã³ã¢ã«åžåä¿æ°ã䜿çšã
ãã
ã®ã¢ã«æ¯ã¯ïŒïŒ2.4ã§ãã€ãããªãããããã®ç®
å®ã«ããã€ãŠã¯ãå®æœäŸïŒã§èçœè³ªããã³ææã«
ã€ããŠç€ºããæ¹æ³ããã³ã¢ã«åžåä¿æ°ã䜿çšã
ãã
ãã®è€åäœã®è¢å
匷床ã¯ãåãæ¿åºŠã§éé¢ã®çº
è²å£ãå±èµ·ããéã«åŸããããã®ãããããªãé«
ããã®ã§ãã€ãã
è²å£ãå±èµ·ããéã«åŸããããã®ãããããªãé«
ããã®ã§ãã€ãã
å®æœäŸ ïŒ
æ§é åŒ
CH3âCH2âïŒïŒ£ïŒïŒ®âCH2
âCH2âCHïŒNHâCH3ïŒ2
ãæããïŒâãšãã«âïŒâïŒïŒâãžã¡ãã«ã¢ãã
ãããã«ïŒâã«ã«ããžã€ããïŒECDIïŒã䜿çšã
ãŠããã€ã«ãã«ãŒïŒC.I.51180ïŒãã¹ã¿ãã€ãã³
ãã«ã¹ ã¢ãŠã¬ãŠã¹ããã®Protein ãšçµåãã
ãã
ãããã«ïŒâã«ã«ããžã€ããïŒECDIïŒã䜿çšã
ãŠããã€ã«ãã«ãŒïŒC.I.51180ïŒãã¹ã¿ãã€ãã³
ãã«ã¹ ã¢ãŠã¬ãŠã¹ããã®Protein ãšçµåãã
ãã
èžçæ°Ž1.2mläžã«Protein A5mgããã³å€§éå°é
ïŒçŽ10åã¢ã«ïŒã®ãã€ã«ãã«ãŒãå«æãã溶液ã«
ECDI50mgãæ·»å ãããæ¹æããªãã宀枩ã§ïŒæ
éåå¿ãç¶ãããã®éãåžHClãæ·»å ããããšã«
ããPHãïŒãªãã6.8ã«ç¶æããããã®åŸãæ°Žã
ïŒãŸãã¯ïŒå亀æããªããçæç©ã48æééæã
ããéæèå ã§åœ¢æãããã³ãã€ãç¶æžæ¿æ¶²ãé
å¿åé¢ã«ããé€å»ãã溶液äžã«ãªãååšããéé¢
ã®ææãSephadex G25ã®ã¯ãããã°ã©ãã€ãŒã«
ããé€å»ããã
ïŒçŽ10åã¢ã«ïŒã®ãã€ã«ãã«ãŒãå«æãã溶液ã«
ECDI50mgãæ·»å ãããæ¹æããªãã宀枩ã§ïŒæ
éåå¿ãç¶ãããã®éãåžHClãæ·»å ããããšã«
ããPHãïŒãªãã6.8ã«ç¶æããããã®åŸãæ°Žã
ïŒãŸãã¯ïŒå亀æããªããçæç©ã48æééæã
ããéæèå ã§åœ¢æãããã³ãã€ãç¶æžæ¿æ¶²ãé
å¿åé¢ã«ããé€å»ãã溶液äžã«ãªãååšããéé¢
ã®ææãSephadex G25ã®ã¯ãããã°ã©ãã€ãŒã«
ããé€å»ããã
è€åäœäžã«ããããã€ã«ãã«ãŒã®æ¿åºŠã«ã€ããŠ
ã¯ãæ°Žäžã«ãããã¢ã«åžåä¿æ°5.8Ã104ã䜿çš
ããλïŒ635ã§æž¬å®ãããèçœè³ªã®æ¿åºŠã«ã€ããŠ
ã¯ãεïŒïŒ ïŒïŒ1.65ã䜿çšããŠÎ»ïŒ275nmã§æž¬å®
ãã玫å€éšã«ãããææã®åžåãè£æ£ããããšã«
ããç®å®ããããŸããããæ£ç¢ºã«ã¯ãã±ã«ããŒã«
ãã¯ãæ³ã«ããçªçŽ ã枬å®ããããšã«ããç®å®ã
ãã
ã¯ãæ°Žäžã«ãããã¢ã«åžåä¿æ°5.8Ã104ã䜿çš
ããλïŒ635ã§æž¬å®ãããèçœè³ªã®æ¿åºŠã«ã€ããŠ
ã¯ãεïŒïŒ ïŒïŒ1.65ã䜿çšããŠÎ»ïŒ275nmã§æž¬å®
ãã玫å€éšã«ãããææã®åžåãè£æ£ããããšã«
ããç®å®ããããŸããããæ£ç¢ºã«ã¯ãã±ã«ããŒã«
ãã¯ãæ³ã«ããçªçŽ ã枬å®ããããšã«ããç®å®ã
ãã
代衚çãªåå¿ã«ãããProtein ïŒãã€ã«ãã«
ãŒã®ã¢ã«æ¯ãïŒïŒïŒãªãã1.5ïŒãã®ã¢ã«æ¯ã¯åå¿
æéããã³åå¿æž©åºŠãå€ããããšã«ããå€ããã
ãïŒã§ãããλïŒ680nmã«ãããè¢å 匷床ãåã
æ¿åºŠã§éé¢ã®çºè²å£ãå±èµ·ããããšã«ãã€ãŠåŸã
ãããã®ããã倧ããè€åäœãåŸãããããã®æ¹
æ³ã§ããŒã¯ããProteni ã¯ã家å å ç«ã°ãã
ãªã³ã§æäœããçŸèµ€è¡çã®Protein âãã€ã«ã
ã«ãŒã«ããåéåå¿ã§ãªãååè¡çåéãã¹ãã«
ãã瀺ãããåŠããçµåå ç«ã°ãããªã³ã®ç¹æ§ã
ç¶æããŠããã
ãŒã®ã¢ã«æ¯ãïŒïŒïŒãªãã1.5ïŒãã®ã¢ã«æ¯ã¯åå¿
æéããã³åå¿æž©åºŠãå€ããããšã«ããå€ããã
ãïŒã§ãããλïŒ680nmã«ãããè¢å 匷床ãåã
æ¿åºŠã§éé¢ã®çºè²å£ãå±èµ·ããããšã«ãã€ãŠåŸã
ãããã®ããã倧ããè€åäœãåŸãããããã®æ¹
æ³ã§ããŒã¯ããProteni ã¯ã家å å ç«ã°ãã
ãªã³ã§æäœããçŸèµ€è¡çã®Protein âãã€ã«ã
ã«ãŒã«ããåéåå¿ã§ãªãååè¡çåéãã¹ãã«
ãã瀺ãããåŠããçµåå ç«ã°ãããªã³ã®ç¹æ§ã
ç¶æããŠããã
å®æœäŸ ïŒ
å®æœäŸïŒã®æ¹æ³ã«åŸã€ãŠãECDIã®ååšäžãã
ã«ã¢ã³èçœè³ªãããªãã¡ãã絚æ¯èæ§ãœãããã¢
ãããã³ïŒHCSïŒããã€ã«ãã«ãŒã§ããŒã¯ããã
ã«ã¢ã³èçœè³ªãããªãã¡ãã絚æ¯èæ§ãœãããã¢
ãããã³ïŒHCSïŒããã€ã«ãã«ãŒã§ããŒã¯ããã
åè©Šè¬ã®éã«ã€ããŠã¯ãHCS2.5mgãã¡ã¿ããŒ
ã«0.05mlã«æº¶è§£ãããã€ã«ãã«ãŒ10-3ããªã¢ã«ã
ãã³ECDI45mgã§ãããåå¿ãæ°ŽïŒmläžã§è¡ãªã€
ãã
ã«0.05mlã«æº¶è§£ãããã€ã«ãã«ãŒ10-3ããªã¢ã«ã
ãã³ECDI45mgã§ãããåå¿ãæ°ŽïŒmläžã§è¡ãªã€
ãã
èçœè³ªã®æ¿åºŠã¯ÎµïŒïŒ
ïŒïŒ8.3ã䜿çšããλïŒ278
ã§æž¬å®ããã
ã§æž¬å®ããã
åŸãããè¢å
è€åäœã¯ã¢ã«æ¯HCGïŒææïŒ
ïŒïŒïŒãæããŠããããã«ã¢ã³ã¯æHCGæè¡æž
ãšåå¿ãããéããã®æåç¹æ§ãç¶æããŠããã
ïŒïŒïŒãæããŠããããã«ã¢ã³ã¯æHCGæè¡æž
ãšåå¿ãããéããã®æåç¹æ§ãç¶æããŠããã
å®æœäŸ ïŒ
ECDIã®ååšäžã§å®¶å
γâå
ç«ã°ãããªã³ãã
ãŒã¯ããããã«ãã«ã€ãžã³ãã«ãŒïŒC.I.52040ïŒ
ã䜿çšããã
ãŒã¯ããããã«ãã«ã€ãžã³ãã«ãŒïŒC.I.52040ïŒ
ã䜿çšããã
åå¿ã®è©³çŽ°ã¯æ¬¡ã®ãšããã§ããã
æ°ŽïŒmläžã«Î³âå
ç«ã°ãããªã³ïŒmgããã³ãã«
ã€ãžã³ãã«ãŒïŒÃ10-4ããªã¢ã«ãå«æããåå¿æ··
åç©ããåžHClã§PH5.6ã«èª¿æŽãããECDI25mgã
å ããæ¹æããªãã宀枩ã§åå¿ãè¡ãªã€ããçŽïŒ
æéåŸãããã«ECDI25mgå ããããã«ïŒæéå
å¿ãç¶ãããæåŸã«ãæ°ŽãŸãã¯ã€ãªã³åŒ·åºŠã®äœã
äžæ§ç·©è¡å€ã«å¯ŸããŠ48ãªãã72æééæããã
ã€ãžã³ãã«ãŒïŒÃ10-4ããªã¢ã«ãå«æããåå¿æ··
åç©ããåžHClã§PH5.6ã«èª¿æŽãããECDI25mgã
å ããæ¹æããªãã宀枩ã§åå¿ãè¡ãªã€ããçŽïŒ
æéåŸãããã«ECDI25mgå ããããã«ïŒæéå
å¿ãç¶ãããæåŸã«ãæ°ŽãŸãã¯ã€ãªã³åŒ·åºŠã®äœã
äžæ§ç·©è¡å€ã«å¯ŸããŠ48ãªãã72æééæããã
ææã«ã€ããŠã¯ã¢ã«åžåä¿æ°ïŒ3.1Ã104ãλïŒ
620nmãèçœè³ªã«ã€ããŠã¯ÎµïŒïŒ ïŒïŒ14ãεïŒ
280nmã«ãã枬å®ããŠã調補ãããè€åäœã®ã¢ã«
æ¯èçœè³ªïŒãã«ã€ãžã³ãã«ãŒãç®å®ãããšããã
ïŒïŒ1.1ãã€ãã
620nmãèçœè³ªã«ã€ããŠã¯ÎµïŒïŒ ïŒïŒ14ãεïŒ
280nmã«ãã枬å®ããŠã調補ãããè€åäœã®ã¢ã«
æ¯èçœè³ªïŒãã«ã€ãžã³ãã«ãŒãç®å®ãããšããã
ïŒïŒ1.1ãã€ãã
ãã®ããã«ããŠããŒã¯ããγâå
ç«ã°ãããªã³
ã¯æγâå ç«ã°ãããªã³ã®ååšäžã§ããã®å ç«ç¹
æ§ãç¶æããŠããã
ã¯æγâå ç«ã°ãããªã³ã®ååšäžã§ããã®å ç«ç¹
æ§ãç¶æããŠããã
第ïŒå³ããã³ç¬¬ïŒå³ã¯ãæ¬çºæã«ãã調補ãã
ãåçš®ã®è€åäœããã³å¯Ÿç §ã®çºå ã¹ãã¯ãã«ã瀺
ãã°ã©ãã§ããã
ãåçš®ã®è€åäœããã³å¯Ÿç §ã®çºå ã¹ãã¯ãã«ã瀺
ãã°ã©ãã§ããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äžè¬åŒ ïŒåŒäžãïœã¯ïŒãªããïŒã®æŽæ°ã§ãããïœã¯åèš
ïœã«çããæŽæ°ãŸãã¯ïŒã§ãããã¯æåãŸãã¯
æäœããéžã°ããèçœè³ªã§ãããã¯æ¶æ©å€ã®æ®
åºã§ãããã¯é žçŽ ååãŸãã¯ã€ãªãŠååã§ã
ããã¯NHãNH2ãNRâ²ããã³NRâ²Râ³ïŒããã§
Râ²ããã³Râ³ã¯åäžãŸãã¯ç°ãªã眮æãŸãã¯æªçœ®
æã®ã¢ã«ãã«åºãã¢ãªãŒã«åºãã¢ãªãŒã«ã¢ã«ãã«
åºãŸãã¯ã¢ã«ãã«ã¢ãªãŒã«åºã§ããïŒããã³
OCORâ²ïŒããã§Râ²ã¯åèšãšåæ矩ãæããïŒã®äž
ããéžã°ããåºã§ãããR1ãR2ãR3ãR4ãR5ã
R7ããã³R8ã¯åäžãŸãã¯ç°ãªãæ°ŽçŽ ååãã¢ã
ãåºãŸãã¯çœ®æãŸãã¯æªçœ®æã®ã¢ã«ãã«åºãã¢ãª
ãŒã«åºãã¢ã«ãã«ã¢ãªãŒã«åºãŸãã¯ã¢ãªãŒã«ã¢ã«
ãã«åºã§ãããR1ããã³R2ããã³ïŒãŸãã¯R7ã
ãã³R8ã¯äºãã«çµåããŠè³éŠç°ãšã®çž®åç°ã圢
æããïŒäŸ¡ã®åºã§ãã€ãŠããããR1ãR2ãR3ã
R4ãR5ãR7ããã³R8ã®ãã¡å°ãªããšãïŒã€ã¯æ¶
æ©å€ãšã®åå¿ã®éâNHâãŸãã¯âïŒïŒ¬åºã
圢æããã¢ããåºã§ãªããã°ãªããªãïŒãæã
ããå ç«èå è©Šè¬ã ïŒ äžè¬åŒ ïŒåŒäžãïœã¯ïŒãªããïŒã®æŽæ°ã§ãããïœã¯åèš
ïœã«çããæŽæ°ãŸãã¯ïŒã§ãããã¯æåãŸãã¯
æäœããéžã°ããèçœè³ªã§ãããã¯æ¶æ©å€ã®æ®
åºã§ãããã¯é žçŽ ååãŸãã¯ã€ãªãŠååã§ã
ããã¯NHãNH2ãNRâ²ããã³NRâ²Râ³ïŒããã§
Râ²ããã³Râ³ã¯åäžãŸãã¯ç°ãªã眮æãŸãã¯æªçœ®
æã®ã¢ã«ãã«åºãã¢ãªãŒã«åºãã¢ãªãŒã«ã¢ã«ãã«
åºãŸãã¯ã¢ã«ãã«ã¢ãªãŒã«åºã§ããïŒããã³
OCORâ²ïŒããã§Râ²ã¯åèšãšåæ矩ãæããïŒã®äž
ããéžã°ããåºã§ãããR1ãR2ãR3ãR4ãR5ã
R7ããã³R8ã¯åäžãŸãã¯ç°ãªãæ°ŽçŽ ååãã¢ã
ãåºãŸãã¯çœ®æãŸãã¯æªçœ®æã®ã¢ã«ãã«åºãã¢ãª
ãŒã«åºãã¢ã«ãã«ã¢ãªãŒã«åºãŸãã¯ã¢ãªãŒã«ã¢ã«
ãã«åºã§ãããR1ããã³R2ããã³ïŒãŸãã¯R7ã
ãã³R8ã¯äºãã«çµåããŠè³éŠç°ãšã®çž®åç°ã圢
æããïŒäŸ¡ã®åºã§ãã€ãŠããããR1ãR2ãR3ã
R4ãR5ãR7ããã³R8ã®ãã¡å°ãªããšãïŒã€ã¯æ¶
æ©å€ãšã®åå¿ã®éâNHâãŸãã¯âïŒïŒ¬åºã
圢æããã¢ããåºã§ãªããã°ãªããªãïŒãæãã
å ç«èå è©Šè¬ã®è£œæ³ã«ãããŠã以äžã®çŸ€(a)ã(b)ã
ãã³(c)ããéžã°ããåã å°ãªããšãïŒçš®é¡ã®åå
ç©ãäºãã«åå¿ãããããšãç¹åŸŽãšãããå ç«è
å è©Šè¬ã®è£œæ³ã (a) æåãŸãã¯æäœããéžã°ããèçœè³ªã (b) äžè¬åŒ ïŒåŒäžãR1ãR2ãR3ãR4ãR5ãR7ãR8ãã
ãã³ïŒ¹ã¯åèšãšåæ矩ã§ããïŒã§è¡šãããå¯èŠ
åã«åžåïŒÎ»maxã¯550ãªãã800nmã«ããïŒ
ãæãããªããµãžã³ãŸãã¯ãã¢ãžã³ããéžã°ã
ãææãããã³ (c) äžè¬ã«åèšææ(b)ã®ã¢ããåºãšåå¿ãããåº
ãæããäºå®èœæ§ç©è³ªã®åœ¢ã®æ¶æ©å€ã ïŒ ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®è£œæ³ã«ãããŠã
åèšïŒã€ã®ååç©ã®éã®åå¿ãããããååç©ã®
ã¿ã䜿çšããŠããŸãã¯ãããååç©çšã®æº¶åªã®å
åšäžã§è¡ããå ç«èå è©Šè¬ã®è£œæ³ã ïŒ ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ãŸãã¯ç¬¬ïŒé èšèŒã®è£œ
æ³ã«ãããŠã奜ãŸããã¯æ°Žãå°ãªããšãïŒçš®é¡ã®
å¡©ã®æ°Žæº¶æ¶²ãŸãã¯ç·©è¡å€æ··åç©ã®ååšäžã§åå¿ã
è¡ããå ç«èå è©Šè¬ã®è£œæ³ã ïŒ ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ãªãã第ïŒé ã®ããã
ãïŒé ã«èšèŒã®è£œæ³ã«ãããŠãPH4.5ãªãã9.5ã«
ãããŠåå¿ãè¡ããå ç«èå è©Šè¬ã®è£œæ³ã ïŒ ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ãªãã第ïŒé ã®ããã
ãïŒé ã«èšèŒã®è£œæ³ã«ãããŠãã»ãŒå®€æž©ã«ãããŠ
åå¿ãè¡ããå ç«èå è©Šè¬ã®è£œæ³ã ïŒ ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ãªãã第ïŒé ã®ããã
ãïŒé ã«èšèŒã®è£œæ³ã«ãããŠãåå¿æž©åºŠã奜ãŸã
ãã¯ïŒâãªããåèšèçœè³ªã®å€æ§æž©åºŠã®ç¯å²ãã
éžã°ãããå ç«èå è©Šè¬ã®è£œæ³ã ïŒ ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ãªãã第ïŒé ã®ããã
ãïŒé ã«èšèŒã®è£œæ³ã«ãããŠãåèšèçœè³ªã«å¯Ÿã
ãŠå€§éå°éã®ææã䜿çšããŠåå¿ãè¡ããå ç«è
å è©Šè¬ã®è£œæ³ã ïŒ ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ãªãã第ïŒé ã®ããã
ãïŒé ã«èšèŒã®è£œæ³ã«ãããŠãåèšèçœè³ªã«å¯Ÿã
ãŠïŒãªãã50åïŒã¢ã«æ¿åºŠïŒã®å€§éå°éã§ææã
䜿çšããŠåå¿ãè¡ããå ç«èå è©Šè¬ã®è£œæ³ã ïŒïŒ ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ãªãã第ïŒé ã®ãã
ããïŒé ã«èšèŒã®è£œæ³ã«ãããŠãèçœè³ªããã³æ
æã®ç·éã«å¯ŸããŠå€§éå°éã®äºå®èœæ§ç©è³ªã䜿çš
ããŠåå¿ãè¡ããå ç«èå è©Šè¬ã®è£œæ³ã
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT24161/81A IT1140209B (it) | 1981-09-25 | 1981-09-25 | Reagenti per immunoluorescenza e metodo per la loro preparazione |
IT24161A/81 | 1981-09-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5866851A JPS5866851A (ja) | 1983-04-21 |
JPH0261707B2 true JPH0261707B2 (ja) | 1990-12-20 |
Family
ID=11212303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP57165174A Granted JPS5866851A (ja) | 1981-09-25 | 1982-09-24 | å ç«è¢å è©Šè¬ããã³ãã®è£œæ³ |
Country Status (6)
Country | Link |
---|---|
US (1) | US4463099A (ja) |
EP (1) | EP0075982B1 (ja) |
JP (1) | JPS5866851A (ja) |
AT (1) | ATE16643T1 (ja) |
DE (1) | DE3267616D1 (ja) |
IT (1) | IT1140209B (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4582791A (en) * | 1983-10-07 | 1986-04-15 | Syntex (U.S.A.) Inc. | Reducing non-specific background in immunofluorescence techniques |
US4918200A (en) * | 1984-07-16 | 1990-04-17 | Huls America Inc. | Chromogenic and fluorogenic silanes and using the same |
US4666862A (en) * | 1984-08-14 | 1987-05-19 | Ortho Diagnostic Systems Inc. | Fluorescent energy transfer with phycobiliproteins |
DE3526565A1 (de) * | 1985-07-25 | 1987-02-05 | Boehringer Mannheim Gmbh | Resorufin-derivate, verfahren zu deren herstellung sowie deren verwendung in fluoreszenzimmunoassays |
US4900686A (en) * | 1987-04-02 | 1990-02-13 | Polaroid Corporation | Fluorescent conjugates and biological diagnostic assay |
US4882284A (en) * | 1987-04-13 | 1989-11-21 | Ortho Pharmaceutical Corporation | Method for quantitating and differentiating white blood cells |
US5360739A (en) * | 1991-12-05 | 1994-11-01 | Miles Inc. | Methods for the identification and characterization of reticulocytes in whole blood |
US5350695A (en) * | 1991-12-05 | 1994-09-27 | Miles Inc. | Methods for the identification and characterization of reticulocytes in whole blood |
US6251687B1 (en) | 1993-09-24 | 2001-06-26 | Biosite Diagnostics, Inc. | Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds |
US7083984B2 (en) | 1993-09-24 | 2006-08-01 | Biosite, Inc. | Hybrid phthalocyanine derivatives and their uses |
US5824799A (en) * | 1993-09-24 | 1998-10-20 | Biosite Diagnostics Incorporated | Hybrid phthalocyanine derivatives and their uses |
US7322927B2 (en) | 1993-09-24 | 2008-01-29 | Biosite, Inc. | Hybrid phthalocyanine derivatives and their uses |
US6238931B1 (en) * | 1993-09-24 | 2001-05-29 | Biosite Diagnostics, Inc. | Fluorescence energy transfer in particles |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2937186A (en) * | 1958-04-29 | 1960-05-17 | Univ Kansas Res Foundation | Isothiocyanate compounds and means of producing the same |
US3028397A (en) * | 1959-03-24 | 1962-04-03 | Borden Co | Isothiocyanates of phthaleins |
GB1533410A (en) * | 1974-12-20 | 1978-11-22 | Block Engineering | Antigen detecting reagents |
US4181650A (en) * | 1975-08-25 | 1980-01-01 | Maier Charles L Jr | Procedure for the assay of pharmacologically immunologically and biochemically active compounds in biological fluids |
CA1070612A (en) * | 1975-10-09 | 1980-01-29 | Robert V. Dahlstrom | Solid phase immunofluorescent assay method |
DE2824917A1 (de) * | 1977-07-13 | 1979-02-01 | Corning Glass Works | Biologisch aktive konjugate |
US4141688A (en) * | 1977-08-11 | 1979-02-27 | Miles Laboratories, Inc. | Composition, device and method for determining reducing agents |
US4363759A (en) * | 1978-04-10 | 1982-12-14 | Miles Laboratories, Inc. | Chemiluminescent-labeled haptens and antigens |
US4193983A (en) * | 1978-05-16 | 1980-03-18 | Syva Company | Labeled liposome particle compositions and immunoassays therewith |
US4238395A (en) * | 1978-07-24 | 1980-12-09 | Miles Laboratories, Inc. | Dimethyl 7-[Ï-N-(phthalimido)alkyl]aminonaphthalene-1,2-dicarboxylates |
US4225485A (en) * | 1978-07-24 | 1980-09-30 | Miles Laboratories, Inc. | Chemiluminescent naphthalene-1,2-dicarboxylic acid hydrazide-labeled polypeptides and proteins |
US4297273A (en) * | 1978-07-24 | 1981-10-27 | Miles Laboratories, Inc. | Chemiluminescent phthalhydrazide-labeled protein and polypeptide conjugates |
DE2912845A1 (de) * | 1979-03-30 | 1980-10-09 | Frenzel Bernd | Verfahren zum nachweis und zur quantitativen bestimmung von antigenen, antikoerpern, oder komplexen aus antigenen und antikoerpern |
US4351760A (en) * | 1979-09-07 | 1982-09-28 | Syva Company | Novel alkyl substituted fluorescent compounds and polyamino acid conjugates |
-
1981
- 1981-09-25 IT IT24161/81A patent/IT1140209B/it active
-
1982
- 1982-09-15 AT AT82201143T patent/ATE16643T1/de not_active IP Right Cessation
- 1982-09-15 DE DE8282201143T patent/DE3267616D1/de not_active Expired
- 1982-09-15 EP EP82201143A patent/EP0075982B1/en not_active Expired
- 1982-09-16 US US06/419,053 patent/US4463099A/en not_active Expired - Fee Related
- 1982-09-24 JP JP57165174A patent/JPS5866851A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
IT1140209B (it) | 1986-09-24 |
EP0075982B1 (en) | 1985-11-21 |
IT8124161A0 (it) | 1981-09-25 |
US4463099A (en) | 1984-07-31 |
EP0075982A1 (en) | 1983-04-06 |
JPS5866851A (ja) | 1983-04-21 |
DE3267616D1 (en) | 1986-01-02 |
ATE16643T1 (de) | 1985-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4199559A (en) | Fluorescence quenching with immunological pairs in immunoassays | |
JP2898264B2 (ja) | çºå ã¢ãªãŒã«ã¹ã«ãããŒãã·ã¢ãã³ææãçšããç©è³ªã®æšèãªããæ€åºæ¹æ³ | |
US3996345A (en) | Fluorescence quenching with immunological pairs in immunoassays | |
US4174384A (en) | Fluorescence quenching with immunological pairs in immunoassays | |
JPH0261707B2 (ja) | ||
CN102892896A (zh) | å ·ææ¹è¿çµæ床çåçžååŠåå æµè¯æ¹æ³ | |
JPS6038655A (ja) | ã€ã ãã¢ãã»ãŒçšç²åè©Šè¬ | |
JP2002303629A (ja) | å ç«ã¯ãããããã€ã¹åã³ãããçšãã被æ€ç©è³ªæž¬å®æ¹æ³ | |
JP3260884B2 (ja) | æšèè€åäœããããçšããåææ³ãçäœé¢é£ç©è³ªã®æ€åºããã³å®éã®æ¹æ³ | |
Ullman et al. | Fluorescence quenching with immunological pairs in immunoassays | |
Wei et al. | Use of synthetic peptides as tracer antigens in fluorescence polarization immunoassays of high molecular weight analytes | |
US6437099B1 (en) | Fluoresceneâactivating antisera and IgG fraction therefrom | |
EP0150905A2 (en) | Anti-idiotype assay using fluorescent energy transfer | |
JP3354975B2 (ja) | èå æšèè©Šè¬ããã³èå å ç«æž¬å®æ³ | |
US4433060A (en) | Chemiluminescent immunoassays with triphenylmethane dyes activated by H.sub. O2 and a chloramine | |
JP3176163B2 (ja) | èå æšèè©Šè¬ããã³èå å ç«æž¬å®æ³ | |
EP0957364B1 (en) | Dye-labeled protein conjugate and method for preparing the same | |
JPS6364746B2 (ja) | ||
US6303757B1 (en) | Indirect polymerized and labelled antibody and method for manufacturing the same | |
EP0955546B1 (en) | Indirect polymerized and labelled antibody and method for manufacturing the same | |
US6307029B1 (en) | Dye-labeled protein conjugate and method for preparing the same | |
EP0957362B1 (en) | Dye-labeled protein conjugate and method for preparing the same | |
US6303758B1 (en) | Dye-labeled and polymerized antibody and method for preparing the same | |
JPH0783925A (ja) | èå æšèè©Šè¬ããã³èå å ç«æž¬å®æ³ | |
US6303759B1 (en) | Dye-labeled and polymerized antibody and method for preparing the same |